Variant report
Variant | esv11457 |
---|---|
Chromosome Location | chr5:164722302-164725972 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541268352 | chr5:164722361-164722362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77922548 | chr5:164722369-164722370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565570530 | chr5:164722382-164722383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532905405 | chr5:164722383-164722384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs36049504 | chr5:164722388-164722389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547951363 | chr5:164722443-164722444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559733548 | chr5:164722488-164722489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114061659 | chr5:164722528-164722529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111569907 | chr5:164722529-164722530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550943503 | chr5:164722542-164722543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530413896 | chr5:164722547-164722548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551800819 | chr5:164722548-164722549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570389956 | chr5:164722598-164722599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534635045 | chr5:164722632-164722633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577208720 | chr5:164722640-164722641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553247418 | chr5:164722648-164722649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568134307 | chr5:164722682-164722683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35261228 | chr5:164722704-164722705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190722769 | chr5:164722715-164722716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554726503 | chr5:164722716-164722717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181963590 | chr5:164722773-164722774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140541877 | chr5:164722825-164722826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183826766 | chr5:164722868-164722869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577599006 | chr5:164722918-164722919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541331663 | chr5:164722951-164722952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530709534 | chr5:164722952-164722953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530190646 | chr5:164722959-164722960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75924630 | chr5:164722980-164722981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74826779 | chr5:164722981-164722982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111564373 | chr5:164722999-164723000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112451495 | chr5:164723000-164723001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548827307 | chr5:164723010-164723011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188105557 | chr5:164723027-164723028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12520661 | chr5:164723066-164723067 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs549758524 | chr5:164723098-164723099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551739260 | chr5:164723148-164723149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181431750 | chr5:164723176-164723177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528111078 | chr5:164723214-164723215 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546530467 | chr5:164723258-164723259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12523003 | chr5:164723285-164723286 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs535283358 | chr5:164723333-164723334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573696678 | chr5:164723347-164723348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557168410 | chr5:164723351-164723352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542419137 | chr5:164723357-164723358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552909118 | chr5:164723374-164723375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559502158 | chr5:164723382-164723383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570145082 | chr5:164723400-164723401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375428914 | chr5:164723451-164723452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537578635 | chr5:164723483-164723484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559112691 | chr5:164723499-164723500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 17603634 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
severe myoclonic epilepsy of infancy | 18294202 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mental retardation | 17124404 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:164718800-164724000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr5:164723200-164724800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr5:164724000-164724200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr5:164724000-164724200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr5:164724200-164724600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:164724200-164725000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr5:164724200-164736000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr5:164725000-164725400 | Enhancers | HUES64 Cell Line | embryonic stem cell |